Skip to main content
. 2015 Nov 17;10(11):e0143371. doi: 10.1371/journal.pone.0143371

Fig 2. Cumulative incidence of disease progression in corticosteroid-naïve patients with sarcoidosis.

Fig 2

The blue line represents the estimation curve of cumulative incidence.